| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 39 | 2015 | 2222 | 2.680 |
Why?
|
| Tomography, X-Ray Computed | 37 | 2021 | 2324 | 2.350 |
Why?
|
| Brain Neoplasms | 9 | 2018 | 371 | 1.550 |
Why?
|
| Brain | 14 | 2020 | 2176 | 1.240 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 8 | 2018 | 239 | 1.230 |
Why?
|
| Adenoma | 5 | 2008 | 132 | 1.080 |
Why?
|
| Contrast Media | 8 | 2015 | 595 | 1.070 |
Why?
|
| Brain Diseases | 4 | 2020 | 78 | 1.020 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2013 | 181 | 1.000 |
Why?
|
| Blood Volume | 5 | 2013 | 47 | 0.970 |
Why?
|
| Hypertension | 27 | 2005 | 1533 | 0.960 |
Why?
|
| Gadolinium DTPA | 3 | 2010 | 48 | 0.950 |
Why?
|
| Pituitary Neoplasms | 5 | 2008 | 52 | 0.890 |
Why?
|
| Humans | 175 | 2021 | 68549 | 0.880 |
Why?
|
| Cerebrovascular Circulation | 4 | 2014 | 296 | 0.860 |
Why?
|
| Astrocytoma | 3 | 2013 | 30 | 0.860 |
Why?
|
| Middle Aged | 94 | 2020 | 21119 | 0.820 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2021 | 373 | 0.820 |
Why?
|
| Brain Edema | 1 | 2021 | 50 | 0.790 |
Why?
|
| Oligodendroglioma | 2 | 2013 | 18 | 0.790 |
Why?
|
| Thalamus | 4 | 2020 | 82 | 0.780 |
Why?
|
| Male | 112 | 2020 | 37283 | 0.750 |
Why?
|
| Female | 114 | 2020 | 38021 | 0.750 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2021 | 92 | 0.740 |
Why?
|
| Basal Ganglia | 1 | 2020 | 45 | 0.730 |
Why?
|
| Intracranial Arteriosclerosis | 7 | 2016 | 134 | 0.730 |
Why?
|
| Adult | 76 | 2020 | 21379 | 0.720 |
Why?
|
| Brain Ischemia | 4 | 2021 | 665 | 0.720 |
Why?
|
| Spinal Cord | 3 | 2010 | 244 | 0.710 |
Why?
|
| Gray Matter | 1 | 2020 | 57 | 0.710 |
Why?
|
| Stroke | 12 | 2021 | 2162 | 0.700 |
Why?
|
| Head and Neck Neoplasms | 5 | 2010 | 561 | 0.700 |
Why?
|
| Meglumine | 2 | 2010 | 16 | 0.690 |
Why?
|
| Aged | 64 | 2020 | 14842 | 0.660 |
Why?
|
| Neuroimaging | 1 | 2020 | 122 | 0.650 |
Why?
|
| Organometallic Compounds | 2 | 2010 | 95 | 0.650 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2009 | 624 | 0.620 |
Why?
|
| Spinal Diseases | 3 | 2014 | 53 | 0.620 |
Why?
|
| Sphenoid Bone | 2 | 2008 | 4 | 0.540 |
Why?
|
| Mouth Neoplasms | 3 | 2008 | 206 | 0.530 |
Why?
|
| Artifacts | 3 | 2020 | 125 | 0.530 |
Why?
|
| Positron-Emission Tomography | 4 | 2010 | 160 | 0.510 |
Why?
|
| Blood Glucose | 4 | 2008 | 631 | 0.490 |
Why?
|
| Cervical Vertebrae | 4 | 2014 | 86 | 0.490 |
Why?
|
| Infratentorial Neoplasms | 2 | 2013 | 7 | 0.480 |
Why?
|
| Myocardial Infarction | 13 | 2000 | 807 | 0.470 |
Why?
|
| Adolescent | 25 | 2020 | 8904 | 0.460 |
Why?
|
| Oropharyngeal Neoplasms | 3 | 2009 | 92 | 0.460 |
Why?
|
| Sensitivity and Specificity | 15 | 2018 | 1753 | 0.450 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2010 | 24 | 0.440 |
Why?
|
| Retrospective Studies | 19 | 2021 | 7268 | 0.440 |
Why?
|
| Prospective Studies | 20 | 2016 | 3703 | 0.440 |
Why?
|
| Carotid Artery, Internal | 2 | 2003 | 85 | 0.430 |
Why?
|
| Neurosurgical Procedures | 3 | 2014 | 98 | 0.430 |
Why?
|
| Aged, 80 and over | 20 | 2020 | 4843 | 0.410 |
Why?
|
| Stents | 5 | 2016 | 657 | 0.410 |
Why?
|
| Diagnosis, Differential | 8 | 2020 | 1140 | 0.390 |
Why?
|
| Intracranial Aneurysm | 2 | 2003 | 87 | 0.390 |
Why?
|
| Central Nervous System Viral Diseases | 2 | 2008 | 5 | 0.380 |
Why?
|
| Anisotropy | 2 | 2008 | 105 | 0.380 |
Why?
|
| Child | 18 | 2016 | 6401 | 0.370 |
Why?
|
| Occipital Bone | 1 | 2010 | 11 | 0.360 |
Why?
|
| Spinal Cord Compression | 2 | 2007 | 23 | 0.350 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 34 | 0.350 |
Why?
|
| Chlorthalidone | 4 | 1998 | 10 | 0.350 |
Why?
|
| Vertebroplasty | 3 | 2014 | 16 | 0.340 |
Why?
|
| Spinal Fusion | 1 | 2010 | 90 | 0.340 |
Why?
|
| Bone Screws | 1 | 2010 | 90 | 0.340 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2008 | 1 | 0.330 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2008 | 2 | 0.330 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 2008 | 10 | 0.330 |
Why?
|
| Cavernous Sinus | 1 | 2008 | 10 | 0.330 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 155 | 0.330 |
Why?
|
| Ethmoid Bone | 1 | 2008 | 18 | 0.320 |
Why?
|
| Cerebellar Diseases | 1 | 2008 | 6 | 0.320 |
Why?
|
| Antihypertensive Agents | 7 | 2011 | 497 | 0.320 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2008 | 7 | 0.320 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 24 | 0.320 |
Why?
|
| Cerebellum | 2 | 2010 | 103 | 0.320 |
Why?
|
| Propranolol | 6 | 1998 | 102 | 0.320 |
Why?
|
| Thoracic Vertebrae | 4 | 2014 | 52 | 0.310 |
Why?
|
| Cranial Sinuses | 1 | 2008 | 11 | 0.310 |
Why?
|
| Radiographic Image Enhancement | 1 | 2009 | 208 | 0.310 |
Why?
|
| Angioplasty | 3 | 2013 | 118 | 0.310 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2008 | 20 | 0.310 |
Why?
|
| Hyperlipidemias | 2 | 1998 | 90 | 0.310 |
Why?
|
| Follow-Up Studies | 14 | 2016 | 3256 | 0.300 |
Why?
|
| Pindolol | 5 | 1998 | 52 | 0.300 |
Why?
|
| Fetal Diseases | 1 | 2008 | 64 | 0.300 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 73 | 0.300 |
Why?
|
| Reproducibility of Results | 9 | 2015 | 2077 | 0.300 |
Why?
|
| Central Nervous System Infections | 1 | 2007 | 2 | 0.300 |
Why?
|
| Iophendylate | 1 | 2007 | 2 | 0.290 |
Why?
|
| Myelography | 1 | 2007 | 10 | 0.290 |
Why?
|
| Meningitis | 1 | 2007 | 23 | 0.290 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2010 | 689 | 0.290 |
Why?
|
| Head Injuries, Penetrating | 2 | 2004 | 3 | 0.280 |
Why?
|
| Cerebellar Neoplasms | 1 | 2006 | 17 | 0.280 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2004 | 61 | 0.270 |
Why?
|
| Wounds, Gunshot | 2 | 2004 | 48 | 0.270 |
Why?
|
| Head | 2 | 2016 | 59 | 0.270 |
Why?
|
| Subdural Space | 1 | 2005 | 5 | 0.260 |
Why?
|
| Spinal Cord Vascular Diseases | 1 | 2005 | 1 | 0.260 |
Why?
|
| Venous Pressure | 1 | 2005 | 7 | 0.260 |
Why?
|
| Spinal Neoplasms | 3 | 2014 | 14 | 0.260 |
Why?
|
| Endophthalmitis | 1 | 2005 | 15 | 0.260 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2005 | 62 | 0.260 |
Why?
|
| Laboratories | 1 | 2005 | 44 | 0.260 |
Why?
|
| Blood Flow Velocity | 4 | 2009 | 172 | 0.260 |
Why?
|
| Radiation Effects | 1 | 2005 | 2 | 0.260 |
Why?
|
| Radiography, Interventional | 3 | 2014 | 49 | 0.250 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 274 | 0.250 |
Why?
|
| Cryptococcus | 1 | 2004 | 7 | 0.250 |
Why?
|
| Cryptococcosis | 1 | 2004 | 28 | 0.240 |
Why?
|
| Young Adult | 7 | 2020 | 5710 | 0.240 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 1465 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2010 | 444 | 0.240 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2013 | 536 | 0.240 |
Why?
|
| Epidural Neoplasms | 1 | 2003 | 1 | 0.240 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 156 | 0.230 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2010 | 138 | 0.230 |
Why?
|
| Rhabdomyosarcoma | 1 | 2003 | 36 | 0.230 |
Why?
|
| Hemangioblastoma | 1 | 2003 | 6 | 0.230 |
Why?
|
| Pharyngeal Diseases | 2 | 2005 | 21 | 0.220 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 799 | 0.220 |
Why?
|
| Cisterna Magna | 1 | 2003 | 3 | 0.220 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2003 | 6 | 0.220 |
Why?
|
| Echinococcosis | 1 | 2003 | 5 | 0.220 |
Why?
|
| Polyarteritis Nodosa | 1 | 2003 | 9 | 0.220 |
Why?
|
| Hypopituitarism | 1 | 2002 | 5 | 0.220 |
Why?
|
| Pituitary Diseases | 1 | 2002 | 4 | 0.220 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2003 | 10 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2016 | 3187 | 0.220 |
Why?
|
| Forensic Medicine | 1 | 2002 | 26 | 0.220 |
Why?
|
| Aneurysm, Ruptured | 1 | 2003 | 40 | 0.220 |
Why?
|
| Nasopharynx | 1 | 2002 | 7 | 0.210 |
Why?
|
| Palate, Hard | 1 | 2002 | 7 | 0.210 |
Why?
|
| Double-Blind Method | 14 | 2011 | 1738 | 0.210 |
Why?
|
| Captopril | 2 | 1993 | 22 | 0.210 |
Why?
|
| Suicide, Attempted | 1 | 2002 | 72 | 0.210 |
Why?
|
| Aging | 1 | 2008 | 911 | 0.200 |
Why?
|
| Orthopedic Procedures | 2 | 2014 | 102 | 0.200 |
Why?
|
| Combined Modality Therapy | 6 | 2013 | 951 | 0.200 |
Why?
|
| Cross-Over Studies | 5 | 2010 | 260 | 0.190 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2000 | 7 | 0.190 |
Why?
|
| Streptokinase | 1 | 2000 | 23 | 0.190 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 694 | 0.180 |
Why?
|
| Blood Pressure | 11 | 1998 | 1449 | 0.180 |
Why?
|
| Diuretics | 4 | 1998 | 96 | 0.180 |
Why?
|
| Arteries | 2 | 2014 | 108 | 0.180 |
Why?
|
| Calcium Channel Blockers | 2 | 2000 | 137 | 0.170 |
Why?
|
| Infant | 4 | 2016 | 2891 | 0.170 |
Why?
|
| Atrophy | 5 | 2010 | 112 | 0.170 |
Why?
|
| Meteorological Concepts | 3 | 1993 | 4 | 0.170 |
Why?
|
| Statistics, Nonparametric | 4 | 2009 | 306 | 0.170 |
Why?
|
| Prognosis | 5 | 2015 | 2093 | 0.170 |
Why?
|
| Bone Cements | 3 | 2014 | 39 | 0.160 |
Why?
|
| Regional Blood Flow | 2 | 2009 | 168 | 0.160 |
Why?
|
| Spinal Cord Injuries | 1 | 2005 | 551 | 0.160 |
Why?
|
| Postoperative Complications | 4 | 2013 | 1615 | 0.160 |
Why?
|
| Dura Mater | 2 | 2010 | 23 | 0.160 |
Why?
|
| Croatia | 5 | 2001 | 8 | 0.160 |
Why?
|
| Constriction, Pathologic | 3 | 2015 | 236 | 0.160 |
Why?
|
| Biopsy | 3 | 2015 | 539 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 4 | 1993 | 239 | 0.160 |
Why?
|
| Observer Variation | 2 | 2010 | 330 | 0.160 |
Why?
|
| Hypokalemia | 1 | 1998 | 12 | 0.160 |
Why?
|
| ROC Curve | 5 | 2009 | 392 | 0.150 |
Why?
|
| Treatment Outcome | 9 | 2016 | 7028 | 0.150 |
Why?
|
| Hippocampus | 3 | 2010 | 471 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2015 | 125 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 2 | 2013 | 198 | 0.150 |
Why?
|
| Infant, Newborn | 3 | 2010 | 2455 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 377 | 0.150 |
Why?
|
| Glioma | 1 | 2018 | 140 | 0.150 |
Why?
|
| Cardiovascular Diseases | 4 | 1998 | 938 | 0.140 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 16 | 0.140 |
Why?
|
| Sella Turcica | 2 | 2008 | 10 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2018 | 275 | 0.140 |
Why?
|
| Hydrocephalus | 1 | 2016 | 40 | 0.140 |
Why?
|
| Dihydropyridines | 1 | 1996 | 13 | 0.140 |
Why?
|
| Submandibular Gland Diseases | 1 | 2015 | 1 | 0.140 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2016 | 10 | 0.130 |
Why?
|
| Submandibular Gland | 1 | 2015 | 34 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2016 | 51 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2016 | 1341 | 0.130 |
Why?
|
| Incidence | 6 | 2013 | 1582 | 0.130 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 60 | 0.130 |
Why?
|
| Subarachnoid Space | 2 | 2007 | 7 | 0.130 |
Why?
|
| Syndrome | 4 | 2013 | 255 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 333 | 0.120 |
Why?
|
| Plasmacytoma | 1 | 2014 | 15 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 189 | 0.120 |
Why?
|
| Radiation Dosage | 4 | 2016 | 419 | 0.120 |
Why?
|
| Radiography | 3 | 2011 | 572 | 0.120 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 2 | 2011 | 20 | 0.120 |
Why?
|
| Medicine | 2 | 1989 | 51 | 0.120 |
Why?
|
| Angiography | 2 | 2005 | 194 | 0.120 |
Why?
|
| Patient Positioning | 1 | 2014 | 15 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 373 | 0.120 |
Why?
|
| Recurrence | 3 | 2016 | 948 | 0.120 |
Why?
|
| Olivary Nucleus | 1 | 2013 | 4 | 0.120 |
Why?
|
| Needles | 1 | 2014 | 34 | 0.120 |
Why?
|
| Disease Management | 1 | 2016 | 248 | 0.120 |
Why?
|
| Indapamide | 2 | 1984 | 3 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 2 | 2013 | 167 | 0.120 |
Why?
|
| Headache | 2 | 2004 | 68 | 0.120 |
Why?
|
| Algorithms | 2 | 2011 | 1195 | 0.110 |
Why?
|
| Zygapophyseal Joint | 1 | 2013 | 5 | 0.110 |
Why?
|
| Antineoplastic Agents | 3 | 2009 | 1070 | 0.110 |
Why?
|
| Embolization, Therapeutic | 2 | 2013 | 150 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 481 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 1993 | 86 | 0.110 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2012 | 15 | 0.110 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 2 | 0.110 |
Why?
|
| Low Back Pain | 1 | 2013 | 45 | 0.110 |
Why?
|
| Warfare | 1 | 1993 | 58 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2012 | 24 | 0.110 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 349 | 0.110 |
Why?
|
| Cervical Atlas | 1 | 2012 | 3 | 0.110 |
Why?
|
| Verapamil | 2 | 1985 | 30 | 0.110 |
Why?
|
| Mortality | 1 | 1993 | 162 | 0.110 |
Why?
|
| Hemangioma | 1 | 2013 | 51 | 0.110 |
Why?
|
| Dipeptides | 1 | 1993 | 89 | 0.100 |
Why?
|
| Temporal Lobe | 2 | 2010 | 125 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 83 | 0.100 |
Why?
|
| Nerve Block | 1 | 2013 | 55 | 0.100 |
Why?
|
| Disease Progression | 2 | 2013 | 1037 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 112 | 0.100 |
Why?
|
| Pregnancy | 4 | 2008 | 2334 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 52 | 0.100 |
Why?
|
| Minoxidil | 2 | 1982 | 4 | 0.100 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2011 | 7 | 0.100 |
Why?
|
| Risk Factors | 9 | 2016 | 5720 | 0.100 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2010 | 5 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2012 | 110 | 0.100 |
Why?
|
| Neuropil | 1 | 2010 | 6 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.100 |
Why?
|
| Ganglioglioma | 1 | 2010 | 11 | 0.100 |
Why?
|
| Biopolymers | 1 | 2011 | 21 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1993 | 185 | 0.090 |
Why?
|
| Enalapril | 1 | 1991 | 86 | 0.090 |
Why?
|
| Body Weight | 2 | 1993 | 554 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2008 | 652 | 0.090 |
Why?
|
| Ear Canal | 1 | 2010 | 24 | 0.090 |
Why?
|
| Ear, Middle | 1 | 2010 | 32 | 0.090 |
Why?
|
| Platelet Aggregation | 3 | 1996 | 127 | 0.090 |
Why?
|
| Otologic Surgical Procedures | 1 | 2010 | 23 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 92 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 100 | 0.090 |
Why?
|
| Afferent Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
| Pyrimidines | 2 | 1982 | 178 | 0.090 |
Why?
|
| Attitude of Health Personnel | 2 | 1986 | 442 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2009 | 69 | 0.090 |
Why?
|
| Cadaver | 1 | 2010 | 136 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 1997 | 106 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 21 | 0.090 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2009 | 24 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 346 | 0.090 |
Why?
|
| Skull Base | 1 | 2010 | 72 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 121 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2009 | 107 | 0.080 |
Why?
|
| Cranial Fossa, Middle | 1 | 2008 | 8 | 0.080 |
Why?
|
| Cisplatin | 1 | 2009 | 192 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2011 | 586 | 0.080 |
Why?
|
| Microcirculation | 1 | 2008 | 77 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 296 | 0.080 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 125 | 0.080 |
Why?
|
| Choriocarcinoma | 1 | 2008 | 7 | 0.080 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2008 | 5 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2008 | 132 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2008 | 2 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2009 | 143 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 211 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1990 | 189 | 0.080 |
Why?
|
| Pyramidal Tracts | 1 | 2008 | 45 | 0.080 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2007 | 7 | 0.080 |
Why?
|
| Equipment Design | 1 | 2009 | 500 | 0.080 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2007 | 13 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 81 | 0.080 |
Why?
|
| Nifedipine | 2 | 2000 | 40 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2008 | 219 | 0.070 |
Why?
|
| Research | 1 | 1989 | 214 | 0.070 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 2007 | 1 | 0.070 |
Why?
|
| Central Nervous System Parasitic Infections | 1 | 2007 | 1 | 0.070 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2007 | 2 | 0.070 |
Why?
|
| Body Burden | 1 | 2007 | 27 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2005 | 1026 | 0.070 |
Why?
|
| Prion Diseases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2007 | 4 | 0.070 |
Why?
|
| Infectious Mononucleosis | 1 | 2007 | 7 | 0.070 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2007 | 30 | 0.070 |
Why?
|
| Survival Rate | 3 | 2013 | 1055 | 0.070 |
Why?
|
| Meningioma | 1 | 2007 | 54 | 0.070 |
Why?
|
| Hematoma, Subdural | 1 | 2007 | 19 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2007 | 89 | 0.070 |
Why?
|
| Radiometry | 1 | 2007 | 64 | 0.070 |
Why?
|
| Ligaments | 1 | 2006 | 14 | 0.070 |
Why?
|
| Science | 1 | 1986 | 15 | 0.070 |
Why?
|
| Radiation Protection | 1 | 2007 | 71 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 1993 | 824 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 892 | 0.070 |
Why?
|
| Ependymoma | 1 | 2006 | 13 | 0.070 |
Why?
|
| Spine | 1 | 2006 | 46 | 0.070 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2004 | 63 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2010 | 310 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2008 | 880 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2006 | 24 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2013 | 2004 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 212 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 166 | 0.070 |
Why?
|
| Abnormalities, Multiple | 2 | 2003 | 109 | 0.070 |
Why?
|
| Intervertebral Disc | 1 | 2006 | 51 | 0.070 |
Why?
|
| Vasodilation | 3 | 1995 | 85 | 0.070 |
Why?
|
| Medulla Oblongata | 1 | 2005 | 19 | 0.070 |
Why?
|
| United States | 4 | 2013 | 7338 | 0.070 |
Why?
|
| Yugoslavia | 6 | 1993 | 10 | 0.070 |
Why?
|
| Mediastinal Diseases | 1 | 2005 | 15 | 0.070 |
Why?
|
| Diazoxide | 2 | 1986 | 9 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 565 | 0.070 |
Why?
|
| Vitreous Body | 1 | 2005 | 26 | 0.060 |
Why?
|
| Drug Interactions | 3 | 1985 | 289 | 0.060 |
Why?
|
| Paranasal Sinuses | 1 | 2007 | 165 | 0.060 |
Why?
|
| Software | 1 | 2008 | 418 | 0.060 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2005 | 10 | 0.060 |
Why?
|
| Hematoma | 1 | 2005 | 47 | 0.060 |
Why?
|
| Injections | 1 | 2005 | 119 | 0.060 |
Why?
|
| Publishing | 1 | 1986 | 89 | 0.060 |
Why?
|
| Fibrosis | 1 | 2007 | 371 | 0.060 |
Why?
|
| Hemodynamics | 3 | 1995 | 705 | 0.060 |
Why?
|
| Time Factors | 4 | 2012 | 4655 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 131 | 0.060 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2004 | 1 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 99 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2005 | 57 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2005 | 110 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2005 | 94 | 0.060 |
Why?
|
| Benzofurans | 1 | 1984 | 21 | 0.060 |
Why?
|
| Syncope | 1 | 1984 | 23 | 0.060 |
Why?
|
| Cerebral Cortex | 3 | 2013 | 415 | 0.060 |
Why?
|
| Amiodarone | 1 | 1984 | 21 | 0.060 |
Why?
|
| Death, Sudden | 1 | 1984 | 24 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2003 | 33 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 1986 | 158 | 0.060 |
Why?
|
| Methyldopa | 2 | 1990 | 4 | 0.060 |
Why?
|
| Electrocardiography | 3 | 1993 | 601 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2003 | 129 | 0.060 |
Why?
|
| Veins | 2 | 1989 | 68 | 0.060 |
Why?
|
| Hospitals | 2 | 1983 | 265 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2003 | 125 | 0.060 |
Why?
|
| Meningeal Neoplasms | 1 | 2003 | 42 | 0.060 |
Why?
|
| Magnetics | 1 | 2003 | 52 | 0.060 |
Why?
|
| Echo-Planar Imaging | 1 | 2003 | 17 | 0.060 |
Why?
|
| Abattoirs | 1 | 2002 | 4 | 0.050 |
Why?
|
| Hydrochlorothiazide | 2 | 1996 | 15 | 0.050 |
Why?
|
| Digoxin | 1 | 1983 | 24 | 0.050 |
Why?
|
| Acromegaly | 1 | 2002 | 5 | 0.050 |
Why?
|
| Circle of Willis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Digitalis Glycosides | 1 | 1982 | 5 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2005 | 839 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 36 | 0.050 |
Why?
|
| Visual Fields | 1 | 2002 | 41 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2002 | 22 | 0.050 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1983 | 21 | 0.050 |
Why?
|
| Brain Stem | 1 | 2003 | 46 | 0.050 |
Why?
|
| Single-Blind Method | 3 | 2013 | 249 | 0.050 |
Why?
|
| Pons | 1 | 2003 | 35 | 0.050 |
Why?
|
| Exercise | 1 | 1988 | 658 | 0.050 |
Why?
|
| Fetus | 1 | 2003 | 157 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 80 | 0.050 |
Why?
|
| Basilar Artery | 1 | 2002 | 38 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2005 | 142 | 0.050 |
Why?
|
| Carotid Stenosis | 2 | 2014 | 163 | 0.050 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 57 | 0.050 |
Why?
|
| Dihydralazine | 1 | 1982 | 1 | 0.050 |
Why?
|
| Lisinopril | 2 | 1993 | 16 | 0.050 |
Why?
|
| Hydralazine | 1 | 1982 | 12 | 0.050 |
Why?
|
| Ticlopidine | 2 | 2013 | 118 | 0.050 |
Why?
|
| Potassium | 3 | 1998 | 168 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1982 | 97 | 0.050 |
Why?
|
| Heart Failure | 2 | 1998 | 1179 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 658 | 0.050 |
Why?
|
| Cerebral Angiography | 2 | 2014 | 151 | 0.050 |
Why?
|
| Aspirin | 2 | 2013 | 295 | 0.050 |
Why?
|
| Labetalol | 1 | 1980 | 10 | 0.050 |
Why?
|
| Swine | 1 | 2002 | 672 | 0.050 |
Why?
|
| Hospital Units | 1 | 1980 | 21 | 0.050 |
Why?
|
| Ethanolamines | 1 | 1980 | 33 | 0.050 |
Why?
|
| Gentamicins | 1 | 2000 | 68 | 0.050 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2000 | 4 | 0.050 |
Why?
|
| Ondansetron | 1 | 2000 | 13 | 0.050 |
Why?
|
| Antiemetics | 1 | 2000 | 8 | 0.050 |
Why?
|
| Sex Determination Analysis | 1 | 1980 | 3 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2003 | 1329 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2000 | 80 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1860 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2001 | 248 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2001 | 110 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2000 | 71 | 0.040 |
Why?
|
| Sports Medicine | 1 | 1980 | 22 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2000 | 64 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2001 | 118 | 0.040 |
Why?
|
| Coronary Disease | 2 | 1993 | 358 | 0.040 |
Why?
|
| Radiotherapy | 2 | 2010 | 86 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2000 | 274 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2008 | 2356 | 0.040 |
Why?
|
| Clinical Trials as Topic | 5 | 1986 | 848 | 0.040 |
Why?
|
| Sclerosis | 2 | 2010 | 32 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2005 | 1549 | 0.040 |
Why?
|
| Dominance, Cerebral | 2 | 2010 | 65 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1980 | 151 | 0.040 |
Why?
|
| Lipids | 2 | 1998 | 298 | 0.040 |
Why?
|
| Greece | 1 | 1998 | 3 | 0.040 |
Why?
|
| Rare Diseases | 2 | 2010 | 41 | 0.040 |
Why?
|
| Specialization | 1 | 1979 | 66 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 596 | 0.040 |
Why?
|
| Pedigree | 1 | 1998 | 159 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1851 | 0.040 |
Why?
|
| Furosemide | 1 | 1998 | 45 | 0.040 |
Why?
|
| Age Distribution | 1 | 1998 | 319 | 0.040 |
Why?
|
| Animals | 4 | 2012 | 20880 | 0.040 |
Why?
|
| Creatinine | 2 | 2000 | 243 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2000 | 546 | 0.040 |
Why?
|
| Heart | 2 | 1993 | 850 | 0.040 |
Why?
|
| Piperazines | 2 | 1990 | 206 | 0.040 |
Why?
|
| Data Collection | 1 | 1998 | 420 | 0.040 |
Why?
|
| Thromboembolism | 1 | 1997 | 91 | 0.040 |
Why?
|
| Stethoscopes | 1 | 1996 | 4 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.030 |
Why?
|
| Hematologic Diseases | 1 | 1976 | 20 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1977 | 107 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2010 | 531 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 103 | 0.030 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1996 | 14 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 32 | 0.030 |
Why?
|
| Ramipril | 1 | 1995 | 10 | 0.030 |
Why?
|
| Amrinone | 1 | 1995 | 1 | 0.030 |
Why?
|
| Iohexol | 1 | 2015 | 82 | 0.030 |
Why?
|
| Dobutamine | 1 | 1995 | 25 | 0.030 |
Why?
|
| Cholestasis | 1 | 1996 | 90 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1996 | 99 | 0.030 |
Why?
|
| Magnesium | 1 | 1995 | 110 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 772 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 467 | 0.030 |
Why?
|
| Cardiac Output, Low | 1 | 1995 | 52 | 0.030 |
Why?
|
| Ovary | 1 | 1995 | 99 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2550 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1995 | 71 | 0.030 |
Why?
|
| Spleen | 1 | 1995 | 301 | 0.030 |
Why?
|
| Actinomycosis | 1 | 1994 | 6 | 0.030 |
Why?
|
| Liver Abscess | 1 | 1994 | 9 | 0.030 |
Why?
|
| Back Pain | 1 | 2014 | 30 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 201 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2014 | 18 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1994 | 24 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 563 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1996 | 222 | 0.030 |
Why?
|
| Efferent Pathways | 1 | 2013 | 15 | 0.030 |
Why?
|
| Vinyl Chloride | 1 | 1993 | 12 | 0.030 |
Why?
|
| Hypotension, Orthostatic | 1 | 1993 | 15 | 0.030 |
Why?
|
| Amlodipine | 1 | 1993 | 31 | 0.030 |
Why?
|
| Hemangiosarcoma | 1 | 1993 | 23 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2014 | 152 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 85 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 237 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 1993 | 68 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 1976 | 232 | 0.030 |
Why?
|
| Arthrography | 1 | 2013 | 13 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 134 | 0.030 |
Why?
|
| Trimethoprim | 1 | 1972 | 8 | 0.030 |
Why?
|
| Sulfamethoxazole | 1 | 1972 | 15 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 1993 | 21 | 0.030 |
Why?
|
| Seasons | 1 | 1993 | 129 | 0.030 |
Why?
|
| Pyelonephritis | 1 | 1972 | 17 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 1976 | 365 | 0.030 |
Why?
|
| Emergencies | 1 | 1993 | 107 | 0.030 |
Why?
|
| Dopamine | 1 | 1995 | 474 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 328 | 0.030 |
Why?
|
| Carcinoid Tumor | 1 | 2012 | 20 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 2012 | 30 | 0.030 |
Why?
|
| Temporal Bone | 1 | 2012 | 53 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2013 | 291 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1425 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 714 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 1993 | 384 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2011 | 80 | 0.020 |
Why?
|
| Nicardipine | 1 | 1991 | 21 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1995 | 450 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 647 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1980 | 1242 | 0.020 |
Why?
|
| Myxoma | 1 | 1990 | 17 | 0.020 |
Why?
|
| Tympanic Membrane | 1 | 2010 | 25 | 0.020 |
Why?
|
| Ear, External | 1 | 1990 | 14 | 0.020 |
Why?
|
| Creatine Kinase | 3 | 1996 | 46 | 0.020 |
Why?
|
| Heart Rate | 1 | 1993 | 568 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 929 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2010 | 25 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 1990 | 33 | 0.020 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2010 | 96 | 0.020 |
Why?
|
| Parahippocampal Gyrus | 1 | 2010 | 15 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Coronary Care Units | 1 | 1990 | 12 | 0.020 |
Why?
|
| Metoprolol | 1 | 1990 | 8 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 35 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 35 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 386 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2010 | 77 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1994 | 375 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1993 | 334 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 2010 | 206 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 737 | 0.020 |
Why?
|
| Limbic System | 1 | 2010 | 106 | 0.020 |
Why?
|
| Patient Admission | 1 | 1990 | 99 | 0.020 |
Why?
|
| Pregnancy Tests | 1 | 1969 | 3 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 1969 | 7 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 113 | 0.020 |
Why?
|
| Amygdala | 1 | 2010 | 159 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1989 | 86 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 1989 | 218 | 0.020 |
Why?
|
| Ethyl Biscoumacetate | 1 | 1988 | 1 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2010 | 342 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 458 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2007 | 10 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 579 | 0.020 |
Why?
|
| Hypertension, Malignant | 1 | 1986 | 1 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 791 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 1988 | 148 | 0.020 |
Why?
|
| Quality Control | 1 | 1986 | 81 | 0.020 |
Why?
|
| Thrombosis | 1 | 1988 | 218 | 0.020 |
Why?
|
| Health Occupations | 1 | 1986 | 28 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2005 | 24 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 464 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 40 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2005 | 15 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2005 | 174 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 1985 | 77 | 0.010 |
Why?
|
| Pulse | 1 | 1984 | 23 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 164 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1985 | 503 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1983 | 34 | 0.010 |
Why?
|
| Suicide | 1 | 2004 | 115 | 0.010 |
Why?
|
| Random Allocation | 1 | 1984 | 442 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1982 | 119 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1419 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 514 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1983 | 223 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2000 | 37 | 0.010 |
Why?
|
| Echocardiography | 2 | 1997 | 515 | 0.010 |
Why?
|
| Urea | 1 | 2000 | 51 | 0.010 |
Why?
|
| Methods | 1 | 1980 | 156 | 0.010 |
Why?
|
| Colorimetry | 1 | 1998 | 22 | 0.010 |
Why?
|
| Photometry | 1 | 1998 | 6 | 0.010 |
Why?
|
| Chlorides | 1 | 1998 | 68 | 0.010 |
Why?
|
| Age of Onset | 1 | 1998 | 188 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 215 | 0.010 |
Why?
|
| Sodium | 1 | 1998 | 161 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 334 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1977 | 163 | 0.010 |
Why?
|
| Epinephrine | 1 | 1977 | 103 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1977 | 117 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1997 | 123 | 0.010 |
Why?
|
| Oxypurinol | 1 | 1976 | 1 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1996 | 4 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1977 | 276 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1977 | 210 | 0.010 |
Why?
|
| Duodenal Ulcer | 1 | 1995 | 16 | 0.010 |
Why?
|
| Abdomen, Acute | 1 | 1995 | 14 | 0.010 |
Why?
|
| Uric Acid | 1 | 1996 | 37 | 0.010 |
Why?
|
| Shock, Hemorrhagic | 1 | 1995 | 33 | 0.010 |
Why?
|
| Fenclonine | 1 | 1975 | 2 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1975 | 22 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 1040 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1995 | 133 | 0.010 |
Why?
|
| Plethysmography, Impedance | 1 | 1995 | 17 | 0.010 |
Why?
|
| Cognition | 1 | 1979 | 512 | 0.010 |
Why?
|
| Analgesics | 1 | 1976 | 118 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1995 | 102 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1997 | 356 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 1997 | 248 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1976 | 234 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1993 | 6 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 648 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1993 | 120 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 1993 | 44 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 1993 | 23 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1993 | 20 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 258 | 0.010 |
Why?
|
| Exercise Test | 1 | 1993 | 242 | 0.010 |
Why?
|
| Educational Status | 1 | 1993 | 273 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1972 | 304 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 1993 | 161 | 0.010 |
Why?
|
| Students, Medical | 1 | 1993 | 210 | 0.010 |
Why?
|
| Heart Atria | 1 | 1990 | 206 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1989 | 567 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 929 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 453 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1988 | 276 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1993 | 2798 | 0.000 |
Why?
|
| Myocardium | 1 | 1990 | 1204 | 0.000 |
Why?
|
| Phenobarbital | 1 | 1983 | 25 | 0.000 |
Why?
|
| Phenytoin | 1 | 1983 | 27 | 0.000 |
Why?
|
| Serotonin Antagonists | 1 | 1975 | 31 | 0.000 |
Why?
|